Literature DB >> 2991366

Effect of specific humoral immunity and some non-specific factors on resistance of volunteers to respiratory coronavirus infection.

K A Callow.   

Abstract

Thirty-three volunteers were inoculated intranasally with coronavirus 229 E, and their responses monitored by antibody rises, symptomatology and virus excretion. These were related to their pre-trial immune status as indicated by concentrations of specific antibodies and non-specific proteins in serum and nasal washings. Both circulating and local specific antibodies were associated with protection from infection and disease, but only specific IgA antibodies of either type appeared to shorten the period of virus shedding. Although total secretory IgA was significantly associated only with reduction of symptoms, total protein in nasal washings appeared to protect against infection also, indicating that other locally produced proteins, not identified, may be associated with resistance. Two of the many factors which may affect the concentration of circulating and local protective proteins and thus influence the outcome of virus inoculation, namely, sex of the volunteer and the interval since the previous cold, were examined. Male volunteers or volunteers who had had evidence of a recent respiratory infection were less likely to be infected, but if they were infected, they had lower clinical scores and stopped shedding virus earlier than the rest. These groups possessed higher concentrations of specific antibodies and non-specific proteins in their pre-challenge sera and/or nasal washings. The significance of these findings is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991366      PMCID: PMC2129501          DOI: 10.1017/s0022172400062410

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  45 in total

1.  Comparison of protective effect of neutralizing antibody in serum and nasal secretions in experimental rhinovirus type 13 illness.

Authors:  J C Perkins; D N Tucker; H L Knopf; R P Wenzel; A Z Kapikian; R M Chanock
Journal:  Am J Epidemiol       Date:  1969-12       Impact factor: 4.897

2.  The proteins in nasal secretion: a longitudinal study of the gammaA-globulin, gammaG-globulin, albumin, siderophilin, and total protein concentrations in nasal washings from adult male volunteers.

Authors:  R D Rossen; A L Schade; W T Butler; J A Kasel
Journal:  J Clin Invest       Date:  1966-05       Impact factor: 14.808

3.  Rhinovirus infections in an industrial population. IV. Infections within families of employees during two fall peaks of respiratory illness.

Authors:  J O Hendley; J M Gwaltney; W S Jordan
Journal:  Am J Epidemiol       Date:  1969-02       Impact factor: 4.897

4.  Neutralizing activity in nasal secretions and serum in resistance of volunteers to parainfluenza virus type 2.

Authors:  L P Tremonti; J S Lin; G G Jackson
Journal:  J Immunol       Date:  1968-09       Impact factor: 5.422

5.  Protective effect of antibody to parainfluenza type 1 virus.

Authors:  C B Smith; R H Purcell; J A Bellanti; R M Chanock
Journal:  N Engl J Med       Date:  1966-11-24       Impact factor: 91.245

6.  The role of nasal secretion and serum antibody in the rhinovirus common cold.

Authors:  T R Cate; R D Rossen; R G Douglas; W T Butler; R B Couch
Journal:  Am J Epidemiol       Date:  1966-09       Impact factor: 4.897

7.  The IgA system. II. The clinical significance of IgA deficiency: studies in patients with agammaglobulinemia and ataxia-telangiectasia.

Authors:  M A South; M D Copper; F A Wollheim; R A Good
Journal:  Am J Med       Date:  1968-02       Impact factor: 4.965

8.  Immunological sex differences. A study of patients with rheumatoid arthritis, their relatives, and controls.

Authors:  K Rhodes; A Scott; R L Markham; M E Monk-Jones
Journal:  Ann Rheum Dis       Date:  1969-03       Impact factor: 19.103

Review 9.  Mucosal antibodies in respiratory and gastrointestinal disease.

Authors:  T B Tomasi; E DeCoteau
Journal:  Adv Intern Med       Date:  1970-06

10.  The proteins in nasal secretion. II. A longitudinal study of IgA and neutralizing antibody levels in nasal washings from men infected with influenza virus.

Authors:  R D Rossen; W T Butler; R H Waldman; R H Alford; R B Hornick; Y Togo; J A Kasel
Journal:  JAMA       Date:  1970-02-16       Impact factor: 56.272

View more
  48 in total

1.  Antibody dependent cellular cytotoxicity against coronavirus 229E-infected cells.

Authors:  M J Holmes; K A Callow; R A Childs; D A Tyrrell
Journal:  Br J Exp Pathol       Date:  1986-08

2.  A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity.

Authors:  Kenta Matsuda; Stephen A Migueles; Jinghe Huang; Lyuba Bolkhovitinov; Sarah Stuccio; Trevor Griesman; Alyssa A Pullano; Byong H Kang; Elise Ishida; Matthew Zimmerman; Neena Kashyap; Kelly M Martins; Daniel Stadlbauer; Jessica Pederson; Andy Patamawenu; Nathaniel Wright; Tulley Shofner; Sean Evans; C Jason Liang; Julián Candia; Angelique Biancotto; Giovanna Fantoni; April Poole; Jon Smith; Jeff Alexander; Marc Gurwith; Florian Krammer; Mark Connors
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

3.  The time course of the immune response to experimental coronavirus infection of man.

Authors:  K A Callow; H F Parry; M Sergeant; D A Tyrrell
Journal:  Epidemiol Infect       Date:  1990-10       Impact factor: 2.451

4.  Prevalence of antibodies to four human coronaviruses is lower in nasal secretions than in serum.

Authors:  Geoffrey J Gorse; Gira B Patel; Joseph N Vitale; Theresa Z O'Connor
Journal:  Clin Vaccine Immunol       Date:  2010-10-13

5.  Mucosal Antibody Response to SARS-CoV-2 in Paediatric and Adult Patients: A Longitudinal Study.

Authors:  Renee W Y Chan; Kate C C Chan; Grace C Y Lui; Joseph G S Tsun; Kathy Y Y Chan; Jasmine S K Yip; Shaojun Liu; Michelle W L Yu; Rita W Y Ng; Kelvin K L Chong; Maggie H Wang; Paul K S Chan; Albert M Li; Hugh Simon Lam
Journal:  Pathogens       Date:  2022-03-24

6.  Smoking, alcohol consumption, and susceptibility to the common cold.

Authors:  S Cohen; D A Tyrrell; M A Russell; M J Jarvis; A P Smith
Journal:  Am J Public Health       Date:  1993-09       Impact factor: 9.308

7.  Coronavirus infection in the laboratory rat: immunization trials using attenuated virus replicated in L-2 cells.

Authors:  D H Percy; R A Scott
Journal:  Can J Vet Res       Date:  1991-01       Impact factor: 1.310

8.  Some recent work at the Common Cold Unit, Salisbury.

Authors:  D A Tyrrell
Journal:  Infection       Date:  1988 Sep-Oct       Impact factor: 3.553

9.  Nasal IgA response in wheezy infants.

Authors:  I M Balfour-Lynn; B Valman; M Silverman; A D Webster
Journal:  Arch Dis Child       Date:  1993-04       Impact factor: 3.791

10.  Sero-epidemiology of human coronaviruses in three rural communities in Ghana.

Authors:  Michael Owusu; Augustina Angelina Sylverken; Philip El-Duah; Godfred Acheampong; Mohammed Mutocheluh; Yaw Adu-Sarkodie
Journal:  Pan Afr Med J       Date:  2021-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.